Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Collet Dandara

Showing results (21-30 of 167) with videos related to

Pageof 17
Sort By:
Omics : a Journal of Integrative Biology|September 15, 2016
Rolling out Efavirenz for HIV Precision Medicine in Africa: Are We Ready for Pharmacovigilance and Tackling Neuropsychiatric Adverse Effects?Collen Masimirembwa, Collet Dandara, Peter Derek Christian Leutscher
Omics : a Journal of Integrative Biology|August 18, 2017
CYP2B6 Haplotype Predicts Efavirenz Plasma Concentration in Black South African HIV-1-Infected Children: A Longitudinal Pediatric Pharmacogenomic StudyRiaan Reay, Collet Dandara, Michelle Viljoen, et al.
Omics : a Journal of Integrative Biology|August 29, 2020
Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal MedicineKevin Dzobo, Harry Chiririwa, Collet Dandara, et al.
Clinical Pharmacology and Therapeutics|June 28, 2019
Herbal Remedies: Throwing Off Phenotype Prediction-A Culprit for Pharmacogenomic-Guided Drug Therapy and Drug SafetyCollet Dandara, Nicholas Ekow Thomford, Tashinga E Bapiro
Frontiers in Genetics|November 8, 2012
ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS PatientsMarelize Swart, Yuan Ren, Peter Smith, et al.
Antiviral Research|December 10, 2013
The role of genetic polymorphisms in cytochrome P450 and effects of tuberculosis co-treatment on the predictive value of CYP2B6 SNPs and on efavirenz plasma levels in adult HIV patientsEmile Bienvenu, Marelize Swart, Collet Dandara, et al.
Frontiers in Allergy|May 25, 2023
Immunogenetics and pharmacogenetics of allergic asthma in AfricaTshegofatso Mabelane, Refiloe Masekela, Collet Dandara, et al.
BMC Cancer|October 14, 2015
The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South AfricaKoushik Chattopadhyay, Anna-Lise Williamson, Annapurna Hazra, et al.
Clinical and Translational Science|March 13, 2024
Pharmacogenetics of tamoxifen in breast cancer patients of African descent: Lack of dataBianca Kruger, Delva Shamley, Nyarai Desiree Soko, et al.
The Pharmacogenomics Journal|August 14, 2018
An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>CNyarai Desiree Soko, Emile Chimusa, Collen Masimirembwa, et al.
Pageof 17

Showing results (21-30 of 167) with videos related to

Sort By:
Pageof 17
Omics : a Journal of Integrative Biology|September 15, 2016
Rolling out Efavirenz for HIV Precision Medicine in Africa: Are We Ready for Pharmacovigilance and Tackling Neuropsychiatric Adverse Effects?Collen Masimirembwa, Collet Dandara, Peter Derek Christian Leutscher
Omics : a Journal of Integrative Biology|August 18, 2017
CYP2B6 Haplotype Predicts Efavirenz Plasma Concentration in Black South African HIV-1-Infected Children: A Longitudinal Pediatric Pharmacogenomic StudyRiaan Reay, Collet Dandara, Michelle Viljoen, et al.
Omics : a Journal of Integrative Biology|August 29, 2020
Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal MedicineKevin Dzobo, Harry Chiririwa, Collet Dandara, et al.
Clinical Pharmacology and Therapeutics|June 28, 2019
Herbal Remedies: Throwing Off Phenotype Prediction-A Culprit for Pharmacogenomic-Guided Drug Therapy and Drug SafetyCollet Dandara, Nicholas Ekow Thomford, Tashinga E Bapiro
Frontiers in Genetics|November 8, 2012
ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS PatientsMarelize Swart, Yuan Ren, Peter Smith, et al.
Antiviral Research|December 10, 2013
The role of genetic polymorphisms in cytochrome P450 and effects of tuberculosis co-treatment on the predictive value of CYP2B6 SNPs and on efavirenz plasma levels in adult HIV patientsEmile Bienvenu, Marelize Swart, Collet Dandara, et al.
Frontiers in Allergy|May 25, 2023
Immunogenetics and pharmacogenetics of allergic asthma in AfricaTshegofatso Mabelane, Refiloe Masekela, Collet Dandara, et al.
BMC Cancer|October 14, 2015
The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South AfricaKoushik Chattopadhyay, Anna-Lise Williamson, Annapurna Hazra, et al.
Clinical and Translational Science|March 13, 2024
Pharmacogenetics of tamoxifen in breast cancer patients of African descent: Lack of dataBianca Kruger, Delva Shamley, Nyarai Desiree Soko, et al.
The Pharmacogenomics Journal|August 14, 2018
An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>CNyarai Desiree Soko, Emile Chimusa, Collen Masimirembwa, et al.
Pageof 17